amgen glp-1 GIPR antagonist antibodies conjugated to peptide are bispecific molecules that decrease weight in obese mice and monkeys: Cell Reports Medicine Amgen and Pfizer's Monthly GLP-1s

Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for body weight reduction, there remains a critical unmet need for complementary strategies that drive selective fat loss and sustain long-term weight reduction

To overcome this limitation, various modifications and delivery strategies to enhance the pharmacokinetic properties and therapeutic efficacy of GLP-1 analogs have been studied

Telehealth company touts its lifestyle plan that emphasizes "long-term, sustainable weight loss" beyond meds.

Antiamyloid therapies have recently changed the treatment landscape

other outcomes were cardiovascular and total death, nonfatal myocardial infarction (MI), nonfatal stroke, hospitalization for heart failure (HHF), and renal outcome

Contains clinically studied ingredients: METABOLAID, ERIOMIN, and Chromium